C, P., A, B., R, Z., ZW, M., N, C., R, I., . . . M, S. (2023). Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. Minerva urology and nephrology, 75(4), 460. https://doi.org/10.23736/S2724-6051.23.05369-7
Chicago Style (17th ed.) CitationC, Porta, et al. "Geographical Differences in the Management of Metastatic De Novo Renal Cell Carcinoma in the Era of Immune-combinations." Minerva Urology and Nephrology 75, no. 4 (2023): 460. https://doi.org/10.23736/S2724-6051.23.05369-7.
MLA (9th ed.) CitationC, Porta, et al. "Geographical Differences in the Management of Metastatic De Novo Renal Cell Carcinoma in the Era of Immune-combinations." Minerva Urology and Nephrology, vol. 75, no. 4, 2023, p. 460, https://doi.org/10.23736/S2724-6051.23.05369-7.